This study seeks to determine whether liraglutide, the study medication, along with intensive behavior therapy, will help adults who are obese to lose weight over one year. Participants will be randomly assigned to receive liraglutide or an inactive placebo. All participants will receive behavior therapy. Participants will inject themselves daily with study medication. The primary measure of the study will be weight change.
The Community Culture Survey (CCS) was developed at the University of Hawai'i-Hilo as a measure of the impact of cultural influences on health. Preliminary data were collected to assess its validity and reliability. We are collecting similar data on a revised version of the CCS to assess its usefulness among more varied samples outside of Hawai'i.
Participants will be adults who complete a brief survey packet including the CCS and questions related to health and quality of life. Basic demographics will also be elicited (age, gender, etc). The survey packets will be completed by the respondent either with paper copies or an online survey site such as Survey Monkey. All responses will be anonymous; the online survey site will be set to anonymous to avoid capturing IP addresses.
This study seeks to determine whether liraglutide, the study medication, will help adolescents who are obese to lose weight over one year. Participants will be randomly assigned to receive liraglutide or an inactive placebo. Participants will injects themselves daily with study medication. Participants will be enrolled in the study for a total of 82 weeks. The primary measure will be weight change and other measures will include blood sugar control and cardiovascular risk factors.